Public Relations

Aban Offshore opens bids for Rs 1,000-cr QIP issue

Offshore oil drilling and production services company Aban Offshore today opened bids for its Rs 1,000-crore qualified institutional placement (QIP) issue. - DCB to raise up to Rs 100 cr via QIP issue - Aban Offshore Q2 net dips 73.32% to Rs 71.4 crore - Aban Offshore net rises 7% to Rs 87 cr - HCL Infosystems opens Rs 500 cr QIP issue - Aban Offshore rises on contract extension - Marg to raise Rs 2,905 cr via GDR, QIP issue The committee of the company"s board also approved the floor price of Rs 1,224.28 per equity share for the proposed QIP issue and fixed November 13 as the date for it, in accordance with Sebi rules. The committee of the board took these decisions at its meeting today, Aban Offshore said in a filing to the Bombay Stock Exchange (BSE). The company also authorised the committee to decide on the appropriate date for closing the bids, it said. The committee further approved the draft preliminary placement document in relation to the allotment of equity shares of Rs 2 each for an amount of Rs 1,000 crore to qualified institutional buyers, it said. The company, which is also engaged in the business of wind-power generation, possesses 20 offshore assets including 15 jack-up offshore drilling rigs. Shares of the company closed at Rs 1,234.75, up 0.46 per cent from previous close on the BSE.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Asian markets have a weak day
The Asian markets ended on a weak note.
Popular Articles

Attitude of some Cong leaders leaves me 'heart-broken': Amar Singh
A day after giving its letter of unconditional support in favour of UPA government to the President, Samajwadi Party today said it felt "heart-broken" at the attitude of certain Congress leaders who have been belittling it.

Dabur plans big expansion in skin care, to launch new brand
FMCG major Dabur is stepping up expansion in the skin care segment, on the back of its acquisition of Fem Care Pharma last year, with plans to expand range of products from the latter"s stable besides launching a new brand of its own.